Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.63 |
| ▸ | HTT | P42858 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23421104 | 0.91 | ALDH1A1 (0.56) | ALDH1A1HTTGAAKDM4EPOLB | |
| SCHEMBL22461529 | 0.89 | ALDH1A1 (0.50) | ALDH1A1HTTGAAKDM4EPOLB | |
| SCHEMBL22461530 | 0.87 | ALDH1A1 (0.48) | ALDH1A1HTTGAAKDM4EPOLB | |
| SCHEMBL6816668 | 0.86 | ALDH1A1 (0.63) | ALDH1A1HTTGAAKDM4EPOLB | |
| SCHEMBL22461531 | 0.85 | ALDH1A1 (0.46) | ALDH1A1HTTGAAKDM4EPOLB | |
| SCHEMBL26479390 | 0.85 | ALDH1A1 (0.46) | ALDH1A1HTTGAAKDM4EPOLB | |
| SCHEMBL22461527 | 0.84 | ALDH1A1 (0.46) | ALDH1A1HTTGAAKDM4EPOLB | |
| SCHEMBL23420931 | 0.84 | ALDH1A1 (0.46) | ALDH1A1HTTGAAKDM4EPOLB | |
| SCHEMBL20656791 | 0.84 | SMN1; SMN2 (0.50) | ALDH1A1HTTGAAKDM4EPOLB | |
| SCHEMBL6215242 | 0.83 | ALDH1A1 (0.71) | ALDH1A1HTTKDM4EPOLBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230135413-A1 | CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY | RICOH COMPANY, LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-11028280-B2 | Composition, cured product, composition stored container, image forming apparatus, and image forming method | RICOH COMPANY, LTD. (JP) | 2021-06-08 | — | — | US | disclosed |
| US-20210155814-A1 | ACTIVE-ENERGY-RAY-CURABLE AQUEOUS COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE AQUEOUS INK, STORED CONTAINER, IMAGE FORMING APPARATUS, IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED PRODUCT | RICOH COMPANY, LTD. (JP) | 2021-05-27 | — | — | US | disclosed |
| US-20210061929-A1 | ACTIVE-ENERGY-RAY-CURABLE COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INK, COMPOSITION STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD AND APPARATUS, CURED PRODUCT, AND DECORATED PRODUCT | RICOH COMPANY, LTD. (JP) | 2021-03-04 | — | — | US | disclosed |
| US-10829631-B2 | Composition, accommodating unit, image forming device, and image forming method | RICOH COMPANY, LTD. (JP) | 2020-11-10 | — | — | US | disclosed |
| US-20200299425-A1 | ACTIVE ENERGY RAY CURABLE COMPOSITION, ACTIVE ENERGY RAY CURABLE INK, COMPOSITION ACCOMMODATING CONTAINER, TWO OR THREE DIMENSIONAL IMAGE FORMING APPARATUS, TWO OR THREE DIMENSIONAL IMAGE FORMING METHOD, CURED MATTER, DECORATIVE MATTER, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATIVE MATERIAL, AND ARTIFICIAL NAIL | RICOH COMPANY, LTD. (JP) | 2020-09-24 | — | — | US | disclosed |
| US-20190293641-A1 | ASSAY | IMPERIAL COLLEGE INNOVATIONS, LTD. (GB) | 2019-09-26 | — | — | US | disclosed |
| US-20190284409-A1 | COMPOSITION, CURED PRODUCT, COMPOSITION STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD. (JP) | 2019-09-19 | — | — | US | disclosed |
| US-10280319-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | RICOH COMPANY, LTD. (JP) | 2019-05-07 | — | — | US | disclosed |
| WO-2018033753-A2 | ASSAY | IMPERIAL INNOVATIONS LIMITED (GB) | 2018-02-22 | — | — | WO | disclosed |
| US-20170137644-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | MORITA MITSUNOBU (JP) | 2017-05-18 | — | — | US | disclosed |
| US-20170137644-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | MORITA MITSUNOBU (JP) | 2017-05-18 | — | — | US | disclosed |
| US-9593248-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | RICOH COMPANY, LTD. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-9593248-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | RICOH COMPANY, LTD. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | RICOH COMPANY, LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | RICOH COMPANY, LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
| EP-2810996-A2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | Ricoh Company, Ltd. (JP) | 2014-12-10 | — | — | EP | disclosed |
| EP-1988078-A1 | Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders | Ortho-McNeil Pharmaceutical, Inc. (US) | 2008-11-05 | — | — | EP | disclosed |
| EP-1165505-B1 | CELL ADHESION-INHIBITING ANTIINFLAMMATORY AND IMMUNE-SUPPRESSIVE COMPOUNDS | ABBOTT LAB (US) | 2004-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10280319-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | CDKN1A, MAPK9, SFRP1 | ALDH1A1 883/4885HTT 2088/4885GAA 3592/4885 |
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | CDKN1A, MAPK9, SFRP1 | ALDH1A1 883/4885HTT 2088/4885GAA 3592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.